ASTERDM - Technical Analysis with Chart Patterns & Indicators
← Back to ListKey Parameters
⭐ Technical Rating: 2.3
Show all parameters (20 more)
🧾 Chart Verdict
Short-term entry zones would be between 745 ₹ (support level near the 50 DMA) and 760 ₹ (resistance at the high of the current channel). An exit strategy should be set at 785 ₹, providing a profit target based on short-term momentum. Given the overvaluation and negative news flow, a cautious approach is warranted; avoiding a long position until there's clear evidence of a turnaround would be prudent.
✅ Positive
The price is currently trading within a defined channel, exhibiting moderate momentum as indicated by the RSI and MACD. Volume remains relatively high, suggesting continued interest in the stock, particularly following recent developments.
⚠️ Limitation
The elevated P/E ratio of 212 compared to the industry average of 49.9 indicates significant overvaluation. This makes the stock vulnerable to a correction if market sentiment shifts negatively. Furthermore, the recent downgrade by MarketsMojo and ICRA upgrades raise concerns about future performance and potentially exacerbate selling pressure.
📉 Company Negative News
Recent news highlights a downgrade from MarketsMojo citing technical and financial concerns, alongside an upgrade of KIMS Healthcare’s long-term rating – this suggests underlying operational issues may be prevalent within the Aster DM group, which could negatively impact investor confidence.
🏭 Industry
The healthcare sector is currently experiencing mixed sentiment due to broader macroeconomic headwinds and increasing regulatory scrutiny. Hospital stocks, in particular, are often sensitive to patient volume trends and operating margins, presenting an added layer of risk for Aster DM.